IO BIOTECH INC (IOBT) Stock Overview
USA - NASDAQ:IOBT - US4497781090 - Common Stock
IOBT Key Statistics, Chart & Performance
The current stock price of IOBT is 2.08 USD. In the past month the price increased by 62.5%. In the past year, price increased by 176.96%.
IOBT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.62 | 385.71B | ||
| AMGN | AMGEN INC | 12.67 | 148.80B | ||
| GILD | GILEAD SCIENCES INC | 14.8 | 142.13B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 23.29 | 101.15B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 61.07B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.27 | 59.35B | ||
| ARGX | ARGENX SE - ADR | 81.59 | 46.29B | ||
| ONC | BEONE MEDICINES LTD-ADR | 5.67 | 38.56B | ||
| INSM | INSMED INC | N/A | 30.85B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.26B | ||
| NTRA | NATERA INC | N/A | 23.13B | ||
| BIIB | BIOGEN INC | 9.05 | 21.24B |
Related stock screener links
About IOBT
Company Profile
IO Biotech, Inc. engages in the development of immune modulating cancer therapies based on its T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The firm develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The firm is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Company Info
IO BIOTECH INC
Ole Maaloes Veh 3
COPENHAGEN DK
Employees: 80
Phone: 4570702980
IO BIOTECH INC / IOBT FAQ
What is the stock price of IO BIOTECH INC today?
The current stock price of IOBT is 2.08 USD. The price increased by 8.9% in the last trading session.
What is the ticker symbol for IO BIOTECH INC stock?
The exchange symbol of IO BIOTECH INC is IOBT and it is listed on the Nasdaq exchange.
On which exchange is IOBT stock listed?
IOBT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for IO BIOTECH INC stock?
12 analysts have analysed IOBT and the average price target is 8.16 USD. This implies a price increase of 292.31% is expected in the next year compared to the current price of 2.08. Check the IO BIOTECH INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is IO BIOTECH INC worth?
IO BIOTECH INC (IOBT) has a market capitalization of 137.03M USD. This makes IOBT a Micro Cap stock.
How many employees does IO BIOTECH INC have?
IO BIOTECH INC (IOBT) currently has 80 employees.
What are the support and resistance levels for IO BIOTECH INC (IOBT) stock?
IO BIOTECH INC (IOBT) has a support level at 1.82. Check the full technical report for a detailed analysis of IOBT support and resistance levels.
Should I buy IO BIOTECH INC (IOBT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of IOBT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of IOBT, evaluating the profitability, health, valuation and growth aspects
- IO BIOTECH INC (IOBT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- IO BIOTECH INC (IOBT) Sales and EPS estimates to see what analysts future expectations are.
- IO BIOTECH INC (IOBT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- IO BIOTECH INC (IOBT) Insider and Institutional Ownership to learn about the owners and their transactions.
- IO BIOTECH INC (IOBT) Stock Chart to make your own analysis
- IO BIOTECH INC (IOBT) Latest news and press-releases to stay up to date.
Does IO BIOTECH INC (IOBT) stock pay dividends?
IOBT does not pay a dividend.
When does IO BIOTECH INC (IOBT) report earnings?
IO BIOTECH INC (IOBT) will report earnings on 2025-11-03, before the market open.
What is the Price/Earnings (PE) ratio of IO BIOTECH INC (IOBT)?
IO BIOTECH INC (IOBT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.53).
What is the Short Interest ratio of IO BIOTECH INC (IOBT) stock?
The outstanding short interest for IO BIOTECH INC (IOBT) is 2.26% of its float. Check the ownership tab for more information on the IOBT short interest.
IOBT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to IOBT. When comparing the yearly performance of all stocks, IOBT is one of the better performing stocks in the market, outperforming 96.88% of all stocks.
IOBT Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to IOBT. IOBT has a bad profitability rating. Also its financial health evaluation is rather negative.
IOBT Financial Highlights
Over the last trailing twelve months IOBT reported a non-GAAP Earnings per Share(EPS) of -1.53. The EPS decreased by -6.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -245.68% | ||
| ROE | -6531.78% | ||
| Debt/Equity | 4.22 |
IOBT Forecast & Estimates
12 analysts have analysed IOBT and the average price target is 8.16 USD. This implies a price increase of 292.31% is expected in the next year compared to the current price of 2.08.